8.47
price up icon1.93%   0.16
after-market Handel nachbörslich: 8.50 0.03 +0.35%
loading

Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.18%
35.82
36.99 29.59 29.01 28.80
Operating Income/Loss
3.18%
-35.82
-36.99 -29.59 -29.01 -28.80
Nonoperating Income/Loss
15.76%
2.768
3.286 3.965 4.48 4.631
Income/Loss From Continuing Operations Before Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Income/Loss From Continuing Operations After Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Net Income/Loss
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Diluted Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Basic Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Diluted Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):